Hip Reconstruction Devices Pipeline Assessment, 2019 Report - ResearchAndMarkets.com

DUBLIN--()--The "Hip Reconstruction Devices - Medical Devices Pipeline Assessment, 2019" report has been added to ResearchAndMarkets.com's offering.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hip Reconstruction Devices pipeline products.

Scope

  • Extensive coverage of the Hip Reconstruction Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hip Reconstruction Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hip Reconstruction Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1. List of Tables & Figures

2 Introduction

2.1 Hip Reconstruction Devices Overview

3 Products under Development

3.1 Hip Reconstruction Devices - Pipeline Products by Stage of Development

3.2 Hip Reconstruction Devices - Pipeline Products by Segment

3.3 Hip Reconstruction Devices - Pipeline Products by Territory

3.4 Hip Reconstruction Devices - Pipeline Products by Regulatory Path

3.5 Hip Reconstruction Devices - Pipeline Products by Estimated Approval Date

3.6 Hip Reconstruction Devices - Ongoing Clinical Trials

4 Hip Reconstruction Devices - Pipeline Products under Development by Companies

4.1 Hip Reconstruction Devices Companies - Pipeline Products by Stage of Development

4.2 Hip Reconstruction Devices - Pipeline Products by Stage of Development

5 Hip Reconstruction Devices Companies and Product Overview

5.1 4iBIO Company Overview

5.2 4-Web Spine, LLC Company Overview

5.3 BioPoly RS LLC Company Overview

5.4 Biotechni SAS Company Overview

5.5 Bonovo Orthopedics Inc Company Overview

5.6 CeramTec GmbH Company Overview

5.7 ConforMIS Inc Company Overview

5.8 Corin Group Plc Company Overview

5.9 DePuy Synthes Inc Company Overview

5.10 Embody Orthopaedic Ltd Company Overview

5.11 Exactech Inc Company Overview

5.12 FH Ortho Inc Company Overview

5.13 Flexable Orthopedics Company Overview

5.14 Fortis Orthopedics Company Overview

5.15 Fraunhofer Institute for Applied Polymer Research Company Overview

5.16 Hip Innovation Technology LLC Company Overview

5.17 Implants International Ltd Company Overview

5.18 Inor Medical Products Ltd Company Overview

5.19 JRI Orthopaedics Ltd Company Overview

5.20 KYOCERA Medical Corp Company Overview

5.21 Limacorporate SpA Company Overview

5.22 MicroPort Scientific Corp Company Overview

5.23 MX Orthopedics Corp Company Overview

5.24 Nano Interface Technology LLC (Inactive) Company Overview

5.25 OrthoGrid Systems Company Overview

5.26 PreSRV Ltd. Company Overview

5.27 Pro-Dex Inc Company Overview

5.28 Renova Orthopedics LLC (Inactive) Company Overview

5.29 Rochester Institute of Technology Company Overview

5.30 SINTEF Company Overview

5.31 SINTX Technologies Inc Company Overview

5.32 Smith & Nephew Plc Company Overview

5.33 Stanford University Company Overview

5.34 University of Auckland Company Overview

5.35 University of South Florida Company Overview

5.36 University of Southampton Company Overview

5.37 University of Warwick Company Overview

5.38 X-NOV Company Overview

5.39 Zimmer Biomet Holdings Inc Company Overview

6 Hip Reconstruction Devices - Recent Developments

6.1 Aug 30, 2019: BRAIN shares strong nine-month figures demonstrating growth in all areas

6.2 Aug 28, 2019: Medtronic announces planned leadership succession

6.3 Aug 20, 2019: Medtronic reports first quarter financial results for

6.4 Aug 12, 2019: Stryker announces commercial structure realignment

6.5 Aug 07, 2019: Wright Medical Group reports 2019 second quarter financial results

6.6 Aug 06, 2019: Materialise reports second quarter 2019 results

6.7 Aug 05, 2019: Orthofix names Jon Serbousek to Succeed CEO

6.8 Aug 05, 2019: Orthofix reports second quarter 2019 results

6.9 Jul 31, 2019: Smith & Nephew second quarter and first half 2019 results

6.10 Jul 29, 2019: SINTX Technologies provides business update

6.11 Jul 26, 2019: Zimmer Biomet announces second quarter 2019 financial results

6.12 Jul 25, 2019: Stryker reports second quarter 2019 operating results

6.13 Jul 24, 2019: Former Medtronic Executive Sean Ginney named VP of Sales at Current Health

6.14 Jul 17, 2019: Humana expands reach of value-based orthopedic specialty care to benefit more Humana Medicare Advantage members

6.15 Jul 10, 2019: Implanet reports 2019 first-half revenue of 3.8million

6.16 Jun 19, 2019: Zimmer Biomet announces chief financial officer transition plan

6.17 Jun 14, 2019: Stryker to invest 200m in RD&I projects in Ireland

6.18 May 30, 2019: OrthAlign announces launch of HipAlign application for surgical navigation in total hip arthroplasty

6.19 May 23, 2019: Medtronic announces fiscal year and fourth quarter 2019 financial results

6.20 May 22, 2019: Smith & Nephew's OXINIUM technology for hips could save the US Health System an estimated $296 Million in

6.21 May 20, 2019: Farrer Park Hospital introduces Robotic-Arm Assisted Surgery for full hip and knee replacement procedures

6.22 May 09, 2019: PROTEOR USA announces new President and CEO

6.23 May 07, 2019: Wright Medical Group N.V. Reports 2019 First Quarter Financial Results

6.24 May 07, 2019: Wright Medical Group names Jason Asper as sr. vice president, chief digital officer

6.25 May 07, 2019: Smith & Nephew: Change of registered office

6.26 May 06, 2019: Orthofix reports first quarter 2019 results

6.27 May 02, 2019: Smith & Nephew first quarter 2019 trading report

6.28 Apr 30, 2019: Materialise announces first quarter 2019 results

6.29 Apr 29, 2019: First successful hip replacement surgery completed with Libertas Hip System

6.30 Apr 26, 2019: Zimmer Biomet announces first quarter 2019 financial results

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/x8hwsu

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900